Prognostic Model of Hypertension

Recruiting now

Conditions studied: Hypertension

In brief

The aim of this study was to establish a registration and monitoring system for hypertension in Xinjiang from 2020 to 2030 to obtain real information about patient basic information, patient characteristics, diagnostic test patterns, treatment options, and hospitalization outcomes (including mortality). Treatment complications, hospitalization costs, and end-of-life events (death, major adverse cardiac events, mild adverse cardiovascular events) in patients with hypertension in Xinjiang; and scientific prevention strategies aimed at effectively preventing the onset of hypertension; Guidelines in clinical practice recommend, analyze and develop effective treatment strategies to optimize management and outcomes for patients with hypertension; and create cost-effective assessment systems.

Key facts

Study ID

NCT06160921

Run by

Xinjiang Medical University

People needed

50000

Starts

2020-01-01

Expected to finish

2030-01-01

Last updated by the study team

2024-03-28

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University

You may not qualify if…

• Patients with secondary hypertension, patients with liver and kidney dysfunction,
• patients with mental disorders, and patients who are unwilling to participate in this trial

Where it is running

• The First Affiliated Hospital of Xinjiang Medicial University — Ürümqi, Xinjiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.